Probiotics, Prebiotics, and Synbiotics for Prevention of Treatment-Induced Gastrointestinal Toxicity in Cancer: A Systematic Review and Network Meta-Analysis
Authors: Zhang, Siyuan; Fan, YingYi; Zhang, Liru; Huang, Wenrui; Ouyang, Xiaojing
Source journal: Probiotics and antimicrobial proteins (2026-11-19)
DOI: 10.1007/s12602-026-11285-3
Abstract
Gastrointestinal (GI) toxicity - particularly diarrhoea, nausea, vomiting, and constipation - is among the most clinically consequential adverse effects of anticancer therapy. Whether probiotics, prebiotics, or synbiotics differ in their capacity to prevent these events remains unknown, as no prior synthesis has simultaneously compared all three intervention classes. We conducted a systematic review and frequentist random-effects network meta-analysis (NMA) of randomised controlled trials (RCTs) evaluating orally administered probiotics, prebiotics, or synbiotics versus control in cancer patients receiving chemotherapy, radiotherapy, or tyrosine kinase inhibitor therapy. Three databases were initially searched to April 1, 2026, with supplementary searches of Web of Science and ClinicalTrials.gov during revision. The primary outcome was any-grade diarrhoea. Secondary outcomes included nausea, vomiting, and constipation. Treatment rankings were derived using P-scores and interpreted as exploratory. Certainty of evidence was assessed with CINeMA and GRADE. Twenty RCTs (2,176 patients; 1988-2024) were included. For diarrhoea (18 trials), probiotic and synbiotic estimates were OR 0.394 (95% CI 0.262-0.593) and OR 0.057 (95% CI 0.016-0.211), respectively. The synbiotic P-score (99.9%) remained exploratory, based on three trials and indirect comparisons. Probiotic estimates for nausea (OR 0.191 (95% CI 0.034-1.090)) and vomiting (OR 0.122 (95% CI 0.0089-1.688)) were not statistically significant. For constipation, probiotic and synbiotic ORs were 0.066 and 0.0044, respectively, with CIs below 1; the latter relied on one sparse trial. Subgroup concordance did not establish equivalent effects across settings; strain-level findings were hypothesis-generating. Certainty was moderate for probiotics and low for synbiotics on diarrhoea, and low to very low for other outcomes. Probiotics and synbiotics were associated with lower odds of some treatment-induced GI events, but the apparent superiority of synbiotics is hypothesis-generating rather than confirmatory because it relies entirely on indirect comparisons. Evidence for prebiotics remains insufficient. The findings do not establish an optimal class, formulation or dose and do not support product-specific clinical recommendations.
Related topics
Related open access articles
- The effects of a marine photosynthetic bacteria Rhodovulum sulfidophilum on the growth and survival rate of Marsupenaeus japonicus (kuruma shrimp)
- An Extended Taxonomic Profile and Metabolic Potential Analysis of Pulque Microbial Community Using Metagenomics
- Impacts of probiotics on feeding technology and its application in aquaculture
- Towards diversification of aquaculture in Ghana: Reproductive response of Sarotherodon melanotheron to locally formulated fish feed
- Grading frequency affect the growth performance and intra−cohort cannibalism in African catfish (Clarias gariepinus, burchell, 1822) culture
- Practical and essential information on water reuse systems in experimental aquaculture production: a descriptive review
Abstract and bibliographic data from PubMed (U.S. National Library of Medicine). Copyright of the abstract belongs to the original publisher or authors.